Global Pain Therapeutics Market to 2023 - Innovative New Products to Address Unmet Need within Chronic Pain and Migraine, and Tackle Opioid Abuse

Report Hive Market Research Released a New Research Report of 147 pages on Title " Global Pain Therapeutics Market to 2023 - Innovative New Products to Address Unmet Need within Chronic Pain and Migraine, and Tackle Opioid Abuse "with detailed Analysis, Forecast and Strategies.

Global Pain Therapeutics Market to 2023 - Innovative New Products to Address Unmet Need within Chronic Pain and Migraine, and Tackle Opioid Abuse

Summary

The pain therapeutics market covers the drugs used for the relief of acute and chronic pain. This market has long been characterized by high levels of generic revenue, derived largely from opioids, which see high levels of usage worldwide and particularly within the US.

However, the last decade has seen the addition of new premium products to the market, including a wave of drugs approved for the treatment of neuropathic pain conditions - a patient population that previously had very poor treatment options. This influx of premium products is forecast to continue through to 2023.

The causes of the resurgence of premium analgesics are multi-faceted, but the primary driver is to meet the many unmet needs of the market, such as the treatment of neuropathic pain and migraines, and the need to limit the risk of abuse associated with many analgesics, primarily opioids. The revived interest in this market has led to a very high frequency of licensing deals for pain products over the past decade.

Request Free Research Sample: https://www.reporthive.com/request-sample.php?id=931462

Scope

- The pain therapeutics market is forecast to reach $28.8 billion in 2023. What are the key market segments driving this growth?
- The pipeline contains over 800 products. What molecule types and molecular targets are in the pipeline? What are the commercial prospects of promising late stage products?
- Despite historical high levels of generic drug development, there is a very high proportion of novel drugs in the pipeline. How do failure rates, clinical trial size and clinical trial duration differ by indication and molecular target?
- Which of the leading companies will have the highest market share by 2023? Which new companies will enter the market?
- What licensing and co-development deals have occurred within this therapy area since 2006?

Reasons to buy

- Understand the current clinical and commercial landscape through a comprehensive analysis of innovation in the pain therapeutics market, in the context of the overall pipeline and current market landscape. The report also includes analysis of the deals landscape, including both licensing deals and co-development deals. Key indications covered in detail include neuropathic pain, inflammatory pain (including osteoarthritis pain) and migraine.
- Understand the current treatment landscape, with portfolios of key marketed products and a focus on historical and forecast sales patterns, and an overview of each drug’s mechanism of action.
- Analyse the pain therapeutics pipeline through a comprehensive review, segmented by stage of development, molecule type and molecular target. This review also provides a detailed look at pain therapeutics clinical trials, to provide an insight into the risk associated with attempting to bring pipeline analgesics to market.
- Predict growth in market size, with in-depth market forecasting from 2016 to 2023. The forecast will provide an understanding of how epidemiology trends, new drug entries and new drug patent expirations will influence market value.
- Identify the key pipeline products, with a particular focus on those due to be brought to market in the near future, as well as sales forecasts for these products.
- Identify the leading companies in the market, in terms of market share and growth. Company analysis determines how dependent the key companies in the market are on revenue derived from pain therapeutic products. In addition, analysis determines the primary factors that will drive market growth for the key companies in the market.
- Assess the licensing and co-development deal landscape for pain therapies.

Table of Contents

Chapter One: Table of Contents
1 Table of Contents 4
1.1 List of Tables 6
1.2 List of Figures 6

Browse Full Report: https://www.reporthive.com/details/global-pain-therapeutics-market-to-2023-innovative-new-products-to-address-unmet-need-within-chronic-pain-and-migraine-and-tackle-opioid-abuse

Chapter Two: Introduction 9
2.1 Disease Cluster Introduction 9
2.2 Symptoms 9
2.2.1 Migraine 9
2.2.2 Inflammatory pain and neuropathic pain 10
2.3 Diagnosis 10
2.4 Pathophysiology 10
2.4.1 Nociceptive pain transmission 10
2.4.2 Pain modulation in the brain 12
2.4.3 Inflammatory pain 13
2.4.4 Migraine 13
2.4.5 Neuropathic pain 14
2.5 Epidemiology 14
2.5.1 Migraine 14
2.5.2 Inflammatory pain 15
2.5.3 Neuropathic pain 16
2.6 Comorbidities and Complications 17
2.7 Treatment 17
2.7.1 Non-steroidal anti-inflammatory drugs 18
2.7.2 Opioid medications 18
2.7.3 Triptans 20
2.7.4 Other medications 20
2.7.5 Conclusion 21

Key questions answered in the report

· What will the market size and the growth rate be in 2021?
· What are the key factors driving the Global Pain Therapeutics Market?
· What are the key market trends impacting the growth of the Global Pain Therapeutics Market?
· What are the challenges to market growth?
· Who are the key vendors in this market space?
· What are the market opportunities and threats faced by the vendors in the Global Pain Therapeutics Market?
· Trending factors influencing the market shares of the Americas, APAC, and EMEA?
· What are the key outcomes of the five forces analysis of the Global Pain Therapeutics Market?

We are a leading repository of market research reports and solutions catering to industries like Comm & Technology, Energy & Power, Food And Beverages, Automotive & Transportation, Healthcare & Life Science etc. This large collection of reports assists organizations in decision-making on aspects such as market entry strategies, market sizing, market share analysis, competitive analysis, product portfolio analysis and opportunity analysis among others. We also assist in determining the best suited and targeted report from our large repository of global reports, company-specific reports and country-level reports.

Mike Ross
Marketing Manager
mike.ross@reporthive.com
http://www.reporthive.com
Phone: +1 312-604-7084
Sainath Nagar, Vadgaon Sheri,
Pune, Maharashtra 411014

This release was published on openPR.